Japanese Journal of Clinical Oncology 31:237-239 (2001)
© 2001 Foundation for Promotion of Cancer Research
Editorial |
Perioperative High Dose Rate Brachytherapy for Soft Tissue Sarcoma
Division of Multidisciplinary Radiotherapy, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
Cancer Cure and Conservative Treatment
Cancer is one of the major causes of death worldwide. In Japan, cancer has been the leading cause of death since 1981. Recent analysis based on the Osaka Cancer Registry shows a significant improvement of 5-year relative survival rates at all sites from 30.4% in 197577 to 41.0% in 1990 (1). Although aggressive treatment such as super-radical surgery plays an important role in the improved outlook with respect to cancer survival, such an improvement may do so with loss of an organ and its function. In certain circumstances physicians as well as patients may wish for more limited surgery with organ preservation to afford better quality of life, which is important for cancer patients and their family. One such example is limb-sparing surgery for soft tissue sarcomas of the extremities. Following such surgery, radiotherapy is an essential adjunct if cure/local control, comparable to
Pre- or Postoperative Radiotherapy
IORT Using Electron Beam or Brachytherapy
HDR-IORT Experience at the Osaka University Hospital
The ABS Recommendations for Brachytherapy of Soft Tissue Sarcomas
Comments on Chun et al.s Paper
REFERENCES